Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022

BUY
$10.54 - $24.2 $653 - $1,500
62 New
62 $2,000
Q2 2022

Aug 12, 2022

SELL
$10.54 - $24.2 $653 - $1,500
-62 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$20.81 - $37.29 $1,290 - $2,311
62 New
62 $1,000
Q3 2021

Oct 06, 2021

SELL
$42.03 - $60.5 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$29.51 - $44.62 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$32.95 - $44.24 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$27.5 - $45.75 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$16.04 - $28.94 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$9.2 - $17.06 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$8.36 - $17.03 $0 - $0
0 New
0 $0
Q4 2018

Jan 23, 2019

SELL
$9.5 - $17.17 $275 - $497
-29 Closed
0 $0
Q2 2018

Aug 07, 2018

SELL
$6.18 - $13.49 $4,542 - $9,915
-735 Reduced 96.2%
29 $0
Q1 2018

Jun 03, 2019

BUY
$4.73 - $6.03 $3,476 - $4,432
735 Added 2534.48%
764 $5,000
Q1 2018

May 09, 2018

SELL
$4.73 - $6.03 $3,476 - $4,432
-735 Reduced 96.2%
29 $0
Q4 2017

Jan 24, 2018

BUY
$4.98 - $6.9 $3,660 - $5,071
735 Added 2534.48%
764 $0
Q2 2016

Jun 03, 2019

BUY
N/A
29
29 $0

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.12B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.